review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Yuri V Bobryshev | Q88065781 |
Ekaterina Ivanova | Q88065783 | ||
Alexander Orekhov | Q51464003 | ||
P2093 | author name string | Dimitry A Chistiakov | |
Nikita G Nikiforov | |||
P2860 | cites work | Combined Inhibition of CCL2, CX3CR1, and CCR5 Abrogates Ly6C hi and Ly6C lo Monocytosis and Almost Abolishes Atherosclerosis in Hypercholesterolemic Mice | Q58149069 |
Macrophage Activation: Glancing into Diversity | Q58862445 | ||
Distribution of macrophage polarization markers in human atherosclerosis | Q63916276 | ||
Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation. Isolation, fractionation and characterization | Q67930751 | ||
Cholesteryl ester hydroperoxides increase macrophage CD36 gene expression via PPARalpha | Q79329017 | ||
Mphi1 and Mphi2 can be re-polarized by Th2 or Th1 cytokines, respectively, and respond to exogenous danger signals | Q80141341 | ||
Oxidized LDL enhances pro-inflammatory responses of alternatively activated M2 macrophages: a crucial role for Krüppel-like factor 2 | Q82937913 | ||
Nrf2 is essential for cholesterol crystal-induced inflammasome activation and exacerbation of atherosclerosis | Q83836296 | ||
Oxidized low-density lipoprotein induces secretion of interleukin-1β by macrophages via reactive oxygen species-dependent NLRP3 inflammasome activation | Q84573835 | ||
Native LDL promotes differentiation of human monocytes to macrophages with an inflammatory phenotype | Q86925854 | ||
Monocytes in atherosclerosis: subsets and functions | Q22251045 | ||
Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages | Q24310677 | ||
Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2. | Q24606271 | ||
Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses | Q24631052 | ||
CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer | Q24642646 | ||
G2A deficiency in mice promotes macrophage activation and atherosclerosis | Q24643942 | ||
Atherosclerosis — An Inflammatory Disease | Q26776972 | ||
Macrophage-mediated cholesterol handling in atherosclerosis | Q26780405 | ||
LDL electronegativity index: a potential novel index for predicting cardiovascular disease | Q26781851 | ||
Autophagy regulates lipid metabolism | Q29547421 | ||
Blood monocytes consist of two principal subsets with distinct migratory properties | Q29614286 | ||
Alternative activation of macrophages: mechanism and functions | Q29614350 | ||
Nonresolving inflammation | Q29616352 | ||
Macrophage activation and polarization | Q29616353 | ||
Macrophages in the pathogenesis of atherosclerosis | Q29617765 | ||
Macrophage activation and polarization: nomenclature and experimental guidelines | Q29620642 | ||
Vascular adhesion molecules in atherosclerosis | Q30444182 | ||
Receptor-independent fluid-phase pinocytosis mechanisms for induction of foam cell formation with native low-density lipoprotein particles | Q30587665 | ||
HDL induces the expression of the M2 macrophage markers arginase 1 and Fizz-1 in a STAT6-dependent process | Q31134072 | ||
Expression of chemokine (C-C motif) ligand 18 in human macrophages and atherosclerotic plaques | Q33387481 | ||
Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation | Q33644572 | ||
Electrophilic nitro-fatty acids: anti-inflammatory mediators in the vascular compartment | Q33746493 | ||
Mechanisms that regulate macrophage burden in atherosclerosis | Q33761114 | ||
Bioactive products generated by group V sPLA(2) hydrolysis of LDL activate macrophages to secrete pro-inflammatory cytokines | Q33771533 | ||
Covalent peroxisome proliferator-activated receptor gamma adduction by nitro-fatty acids: selective ligand activity and anti-diabetic signaling actions | Q33782620 | ||
HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells | Q33868782 | ||
Lipoprotein subfractions and cardiovascular disease risk | Q34119636 | ||
Nomenclature of monocytes and dendritic cells in blood. | Q34125860 | ||
Macrophage ABCA1 reduces MyD88-dependent Toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterol. | Q34188006 | ||
Macrophages in atherosclerosis: a dynamic balance. | Q34368005 | ||
Alternatively activated macrophages differentially express fibronectin and its splice variants and the extracellular matrix protein betaIG-H3. | Q52965268 | ||
Susceptibility of monocytes to activation correlates with atherogenic mitochondrial DNA mutations. | Q53440904 | ||
Activating transcription factor 1 directs Mhem atheroprotective macrophages through coordinated iron handling and foam cell protection. | Q55055144 | ||
PPARγ Activation Primes Human Monocytes into Alternative M2 Macrophages with Anti-inflammatory Properties | Q57244208 | ||
Macrophages and immune cells in atherosclerosis: recent advances and novel concepts | Q38462573 | ||
Study of the activated macrophage transcriptome | Q38599909 | ||
Effect of natural genetic variation on enhancer selection and function. | Q38866012 | ||
Specificity of action of colony-stimulating factors in the differentiation of granulocytes and macrophages | Q39503471 | ||
7-ketocholesteryl-9-carboxynonanoate induced nuclear factor-kappa B activation in J774A.1 macrophages | Q39646631 | ||
Palmitic acid enhances lectin-like oxidized LDL receptor (LOX-1) expression and promotes uptake of oxidized LDL in macrophage cells | Q39794807 | ||
Macrophages generate reactive oxygen species in response to minimally oxidized low-density lipoprotein: toll-like receptor 4- and spleen tyrosine kinase-dependent activation of NADPH oxidase 2. | Q39903564 | ||
Oxysterol-induced up-regulation of MCP-1 expression and synthesis in macrophage cells | Q40363965 | ||
Phenomenon of individual difference in human monocyte activation | Q40802228 | ||
ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation | Q41789790 | ||
Autophagy links inflammasomes to atherosclerotic progression. | Q41825615 | ||
CXC chemokine ligand 4 induces a unique transcriptome in monocyte-derived macrophages | Q41859211 | ||
Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors | Q42101285 | ||
The adenosine-dependent angiogenic switch of macrophages to an M2-like phenotype is independent of interleukin-4 receptor alpha (IL-4Rα) signaling | Q42234391 | ||
Human atherosclerotic plaque alternative macrophages display low cholesterol handling but high phagocytosis because of distinct activities of the PPARγ and LXRα pathways. | Q42557215 | ||
Molecular signaling operated by a diet-compatible mixture of oxysterols in up-regulating CD36 receptor in CD68 positive cells | Q43120227 | ||
Low density lipoprotein-containing circulating immune complexes and coronary atherosclerosis | Q43566437 | ||
The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. | Q43925988 | ||
Oxidized cholesteryl linoleates stimulate endothelial cells to bind monocytes via the extracellular signal-regulated kinase 1/2 pathway | Q43957606 | ||
The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages | Q44542540 | ||
Latent enhancers activated by stimulation in differentiated cells | Q46305342 | ||
Free fatty acids in the presence of high glucose amplify monocyte inflammation via Toll-like receptors | Q34501763 | ||
The CD14+ CD16+ blood monocytes: their role in infection and inflammation | Q34585882 | ||
Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. | Q34659689 | ||
αMβ₂ integrin activation prevents alternative activation of human and murine macrophages and impedes foam cell formation | Q34822654 | ||
Electrophilic fatty acids regulate matrix metalloproteinase activity and expression. | Q34963415 | ||
Molecular regulation of HDL metabolism and function: implications for novel therapies | Q35191066 | ||
Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata | Q35251005 | ||
Macrophages in immunopathology of atherosclerosis: a target for diagnostics and therapy. | Q35595537 | ||
Macrophage autophagy plays a protective role in advanced atherosclerosis | Q35877886 | ||
The origin and kinetics of mononuclear phagocytes | Q36269269 | ||
Efficient clearance of early apoptotic cells by human macrophages requires M2c polarization and MerTK induction | Q36301713 | ||
Role of cholesterol and lipid organization in disease | Q36327808 | ||
Scavenger receptors in atherosclerosis: beyond lipid uptake | Q36489900 | ||
High-density lipoprotein inhibits human M1 macrophage polarization through redistribution of caveolin-1. | Q36546975 | ||
Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR. | Q36683297 | ||
Cholesteryl ester hydroperoxides are biologically active components of minimally oxidized low density lipoprotein | Q36749185 | ||
Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators | Q36879456 | ||
Coronary intraplaque hemorrhage evokes a novel atheroprotective macrophage phenotype | Q37150841 | ||
Loss of SR-A and CD36 activity reduces atherosclerotic lesion complexity without abrogating foam cell formation in hyperlipidemic mice | Q37151524 | ||
Emigration of monocyte-derived cells to lymph nodes during resolution of inflammation and its failure in atherosclerosis | Q37260168 | ||
Mechanisms and consequences of macrophage apoptosis in atherosclerosis | Q37308942 | ||
Heterogeneous in vivo behavior of monocyte subsets in atherosclerosis | Q37446568 | ||
Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses | Q37606964 | ||
Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells | Q37615062 | ||
Pyrin critical to macrophage IL-1beta response to Francisella challenge | Q37661273 | ||
Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity | Q37830940 | ||
Macrophage Phenotype Modulation by CXCL4 in Atherosclerosis | Q37978620 | ||
Heme and haemoglobin direct macrophage Mhem phenotype and counter foam cell formation in areas of intraplaque haemorrhage | Q38024990 | ||
Monocytes and macrophages: developmental pathways and tissue homeostasis | Q38214042 | ||
Macrophage phenotypes and their modulation in atherosclerosis | Q38226669 | ||
The complexity of cell composition of the intima of large arteries: focus on pericyte-like cells | Q38228732 | ||
The transcriptional regulator network of human inflammatory macrophages is defined by open chromatin. | Q38299850 | ||
Macrophage phenotypic plasticity in atherosclerosis: The associated features and the peculiarities of the expression of inflammatory genes | Q38371352 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | macrophage | Q184204 |
transcriptome | Q252857 | ||
cell | Q7868 | ||
pathophysiology | Q1135939 | ||
atherosclerosis | Q12252367 | ||
biomedical investigative technique | Q66648976 | ||
hemic and immune systems | Q70202933 | ||
macromolecular substance | Q75174158 | ||
P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
P304 | page(s) | 9582430 | |
P577 | publication date | 2016-07-17 | |
P1433 | published in | BioMed Research International | Q17509958 |
P1476 | title | Macrophages and Their Role in Atherosclerosis: Pathophysiology and Transcriptome Analysis | |
P478 | volume | 2016 |
Q57152800 | Antibody-based tracers for PET/SPECT imaging of chronic inflammatory diseases |
Q89580211 | Cardiometabolic-Based Chronic Disease, Adiposity and Dysglycemia Drivers: JACC State-of-the-Art Review |
Q97074379 | Cell Membrane-Based Biomimetic Nanoparticles and the Immune System: Immunomodulatory Interactions to Therapeutic Applications |
Q64259549 | Conjugated Linoleic Acid Effects on Cancer, Obesity, and Atherosclerosis: A Review of Pre-Clinical and Human Trials with Current Perspectives |
Q64097695 | Correlation between angiopoietin-like proteins in inflammatory mediators in peripheral blood and severity of coronary arterial lesion in patients with acute myocardial infarction |
Q93052031 | Crosstalk Between Hypoxia and ER Stress Response: A Key Regulator of Macrophage Polarization |
Q56376971 | Deficiency of Dab2 (Disabled Homolog 2) in Myeloid Cells Exacerbates Inflammation in Liver and Atherosclerotic Plaques in LDLR (Low-Density Lipoprotein Receptor)-Null Mice-Brief Report |
Q64100195 | Deletion of hematopoietic Dectin-2 or CARD9 does not protect against atherosclerotic plaque formation in hyperlipidemic mice |
Q53422544 | Discovering Macrophage Functions Using In Vivo Optical Imaging Techniques. |
Q64936166 | Effects of Exercise to Improve Cardiovascular Health. |
Q89978016 | Electronegative LDL Promotes Inflammation and Triglyceride Accumulation in Macrophages |
Q61811325 | Evidence of association of circulating epigenetic-sensitive biomarkers with suspected coronary heart disease evaluated by Cardiac Computed Tomography |
Q41607052 | Expression and anti-inflammatory role of activin receptor-interacting protein 2 in lipopolysaccharide-activated macrophages. |
Q64069069 | Familial aggregation of myocardial infarction and coaggregation of myocardial infarction and autoimmune disease: a nationwide population-based cross-sectional study in Taiwan |
Q57169759 | Foam cell formation: A new target for fighting atherosclerosis and cardiovascular disease |
Q92307101 | Human amnion mesenchymal stem cells attenuate atherosclerosis by modulating macrophage function to reduce immune response |
Q91863248 | ILC2 transfers to apolipoprotein E deficient mice reduce the lipid content of atherosclerotic lesions |
Q47097556 | Identification of Key Pathways and Genes in Advanced Coronary Atherosclerosis Using Bioinformatics Analysis. |
Q91867240 | Immune and Smooth Muscle Cells Interactions in Atherosclerosis: How to Target a Breaking Bad Dialogue? |
Q39150057 | Interaction of endothelial cells with macrophages-linking molecular and metabolic signaling |
Q63915886 | Macrophages and Cardiovascular Health |
Q52759762 | Mechanisms of foam cell formation in atherosclerosis. |
Q64087480 | MicroRNAs or Long Noncoding RNAs in Diagnosis and Prognosis of Coronary Artery Disease |
Q64966156 | Monocytes, Macrophages, and Metabolic Disease in Atherosclerosis. |
Q64271996 | Multi-level remodeling of transcriptional landscapes in aging and longevity |
Q51790342 | NO Signaling in the Cardiovascular System and Exercise. |
Q38713136 | PTEN/PI3k/AKT Regulates Macrophage Polarization in Emphysematous mice. |
Q92753286 | Proinflammatory Action of a New Electronegative Low-Density Lipoprotein Epitope |
Q37612085 | ROS-Dependent Activation of Autophagy through the PI3K/Akt/mTOR Pathway Is Induced by Hydroxysafflor Yellow A-Sonodynamic Therapy in THP-1 Macrophages. |
Q47251361 | Recent Advances in Managing Atherosclerosis via Nanomedicine. |
Q64937621 | Role of Macrophages in Cardioprotection. |
Q33835025 | STAT6 Upregulation Promotes M2 Macrophage Polarization to Suppress Atherosclerosis |
Q98613668 | Select Macrophage Noncoding RNAs of Interest in Cardiovascular Disease |
Q92572643 | Selenomethionine supplementation reduces lesion burden, improves vessel function and modulates the inflammatory response within the setting of atherosclerosis |
Q92543205 | Single-Cell RNA Sequencing of the Cardiovascular System: New Looks for Old Diseases |
Q61051844 | Targeting Macrophages as a Potential Therapeutic Intervention: Impact on Inflammatory Diseases and Cancer |
Q33633543 | Targeting mannose receptor expression on macrophages in atherosclerotic plaques of apolipoprotein E-knockout mice using 111In-tilmanocept |
Q61812290 | Targeting mannose receptor expression on macrophages in atherosclerotic plaques of apolipoprotein E-knockout mice using Ga-NOTA-anti-MMR nanobody: non-invasive imaging of atherosclerotic plaques |
Q90733135 | The Dual Role of Surfactant Protein-D in Vascular Inflammation and Development of Cardiovascular Disease |
Q92504508 | The Use of Nutraceuticals to Counteract Atherosclerosis: The Role of the Notch Pathway |
Q91523850 | The mechanisms of traditional Chinese medicine underlying the prevention and treatment of atherosclerosis |
Q88640276 | Unified nexus of macrophages and maresins in cardiac reparative mechanisms |
Q92620189 | Vindoline-A Natural Product from Catharanthus Roseus Reduces Hyperlipidemia and Renal Pathophysiology in Experimental Type 2 Diabetes |
Q49588540 | [Effects of simvastatin on aortic vascular endothelial cell apoptosis and Bcl-2 protein expression in a rat model of atherosclerosis]. |
Q100385947 | bFGF blockade reduces intraplaque angiogenesis and macrophage infiltration in atherosclerotic vein graft lesions in ApoE3*Leiden mice |
Search more.